ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE)

  • ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE) 1
  • ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE) 2
  • ANTIBIOTIC INJECTABLES Meropenem(FOR CRITICAL CARE) 3
Product Description

CEFEPIME FOR INJECTION | CEFTRIAXONE | CEFTAZIDIME FOR INJECTION | CEFOPERAZONE + SULBACTAM FOR INJECTION | CEFUROXIME FOR INJECTION | CEFOTAXIME FOR INJECTION | CEFTAZIDIME AVIBACTAM FOR INJECTION | CEFTRIAXONE SULBACTAM FOR INJECTION | ELORES: CEFTRIAXONE, SULBACTAM & EDTA FOR INJECTION | AZTREONAM FOR INJECTION | IMIPENEM AND CILASTATIN FOR INJECTION | MEROPENEM FOR INJECTION | TEICOPLANIN FOR INJECTION | VANCOMYCIN FOR INJECTION | POLYMYXIN B SULFATE FOR INJECTION | AMIKACIN | CLINDAMYCIN INJECTION | MOXIFLOXACIN

Read more Show less

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile
Categories
more categories Show less
Specifications
  • Details
    Venus Remedies Limited/Venus Pharma GmbH, globally recognized for their unwavering commitment to quality and innovation, proudly holds EU-GMP certification in injectable manufacturing, EU APPROVED INJECTABLES MANUFACTUER
  • Selling Points
    International Approvals/Standards; Product Features; Product Performance; Prompt Delivery; Quality Service; Reputation; Sustainability; Venus Remedies is considered among the top-class manufacturers of oncological, carbapenem and cephalosporin injectable products. The company is contributing substantially in the oncology segment across the globe through its wide array of key products, which include Docetaxel, Paclitaxel, Gemcitabine, Oxaliplatin, Bortezomib and Pemetrexed.
  • Model
    Meropenem
  • Supplied from
    Germany; India
More specifications Fewer specifications
Sales Markets
Show more Show less

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile

More Products from Venus Pharma GmbH (5)

  • ONCOLOGY LIQUID INJECTABLES

    Product ONCOLOGY LIQUID INJECTABLES

    CARBOPLATIN | CISPLATIN | CYTARABINE LIQUID | DOCETAXEL WITH SOLVENT | DOCETAXEL (CTD) SINGLE VIAL | DOXORUBICIN | EPIRUBICINE | ETOPOSIDE  | IRINOTECAN | LEUCOVORIN CALCIUM | METHOTREXATE | OXALIPLATIN | PLERIXAFOR | PACLITAXEL  | VINCRISTINE | 5-FLOUROURACIL | FULVESTRANT
  • ONCOLOGY LYOPHILIZED INJECTABLES

    Product ONCOLOGY LYOPHILIZED INJECTABLES

    AZACITIDINE | BENDAMUSTINE  | BLEOMYCIN | BORTEZOMIB | CYTARABINE  | DACARBAZINE | EPIRUBICIN  | GEMCITABINE | PEMETREXED | TOPOTECAN | ZOLENDRONIC ACID
  • PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

    Product PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

    ENOXAPARIN PFS 100MG/ML

  • Product List for Venus Remedies Limied-CPHI 2024

    Product Product List for Venus Remedies Limied-CPHI 2024

    At VENUS REMEDIES LIMITED, we approach business partnerships with a strategic mindset, fostering collaboration that is not only successful in the short term but also sustainable and mutually beneficial in the long run.
  • OTHER INJECTABLES

    Product OTHER INJECTABLES

    REMDESIVIR FOR INJECTION | ACECLOFENAC | CISATRACURIUM BESYLATE | CITICOLINE | DEXMETOMIDINE | L-ORNITHINE L-ASPARTATE | MIDAZOLAM INJ | N-ACETYLCYSTEINE | SUGAMMADEX| PARACETAMOL

Venus Pharma GmbH resources (2)